Head-To-Head Survey: DocGo (NASDAQ:DCGO) vs. CochLear (OTCMKTS:CHEOY)

DocGo (NASDAQ:DCGOGet Free Report) and CochLear (OTCMKTS:CHEOYGet Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for DocGo and CochLear, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DocGo 1 3 3 0 2.29
CochLear 0 2 1 2 3.00

DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 316.67%. Given DocGo’s higher probable upside, equities analysts clearly believe DocGo is more favorable than CochLear.

Insider & Institutional Ownership

56.4% of DocGo shares are held by institutional investors. 3.8% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares DocGo and CochLear’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
DocGo -56.61% -34.41% -23.82%
CochLear N/A N/A N/A

Risk & Volatility

DocGo has a beta of 0.98, meaning that its stock price is 2% less volatile than the S&P 500. Comparatively, CochLear has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500.

Earnings and Valuation

This table compares DocGo and CochLear”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
DocGo $322.20 million 0.17 -$182.40 million ($1.85) -0.31
CochLear $1.53 billion 5.20 $251.85 million N/A N/A

CochLear has higher revenue and earnings than DocGo.

Summary

CochLear beats DocGo on 9 of the 13 factors compared between the two stocks.

About DocGo

(Get Free Report)

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.